Back to Dashboard
NVAX · Healthcare

Novavax Inc

USA Healthcare Filing: 2026-06-30
29/100
Smart-money confidence
Below average interest

No standout activity across the feeds we track.

Stocks scoring 0–25 beat the S&P 500 39.9% of the time over the next three months, since 2015. How we measured this →

8
hedge funds
hold it · 2 added, 4 trimmed
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$1.3B
Industry
Biotechnology
Sector
Healthcare
Exchange
NasdaqGS
About NOVAVAX INC

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg,…

Who's behind the signal
Every informed buyer we can see on NVAX, across all three feeds.
Hedge funds · 8
Citadel Advisors Increased +51%
AQR Capital Management Increased +706%
Coatue Management Unchanged
D.E. Shaw & Co Decreased −27%
Point72 (Steve Cohen) Decreased −56%
+2 more in the full breakdown below ↓
Congress · 1
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 2 on record
Disclosures from 2020-08-17 to 2020-10-13
The newest disclosure we hold for this stock is 2020-10-13. That is the end of our data, not necessarily the end of the trading — our bulk STOCK Act archive stops there and newer filings arrive through a separate live feed. Treat the absence of recent rows as “not covered”, not as “no trades”.
Trade date Member Chamber Action Amount
2020-10-13 Pat Roberts · R-KS Senate Sold $1,001 - $15,000
2020-08-17 Pat Roberts · R-KS Senate Bought $1,001 - $15,000
Not a model pick — but on our radar. NOVAVAX INC isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
0
New positions
2
Increasing
4
Decreasing
2
Unchanged
Price History
Loading price data...
Ctrl/⌘ + scroll or pinch to zoom · drag to measure · double-click to reset Pinch to zoom · drag sideways to move through time
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to NOVAVAX INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell NOVAVAX INC or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订 · 隐私